{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:54:19Z","timestamp":1785236059590,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T00:00:00Z","timestamp":1478131200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1979-z","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T12:00:46Z","timestamp":1478174446000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome"],"prefix":"10.1186","volume":"16","author":[{"given":"Claudia M. D.","family":"de Maio Carrilho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa Marques","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Gaudereto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamile S.","family":"Perozin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Ragassi","family":"Urbano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos H.","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cintia M. C.","family":"Grion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Sara S.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia F.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,3]]},"reference":[{"key":"1979_CR1","unstructured":"Adler A, Carmeli Y. Dissemination of the Klebsiella pneumoniae carbapenemase in the health care settings: tracking the trails of an elusive offender. MBio. 2011;2(6):10,1128;mBio.00280,11"},{"issue":"4","key":"1979_CR2","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S1473-3099(09)70054-4","volume":"9","author":"P Nordmann","year":"2009","unstructured":"Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumonia carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9(4):228\u201336.","journal-title":"Lancet Infect Dis"},{"key":"1979_CR3","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","volume":"13","author":"LS Munoz-Price","year":"2013","unstructured":"Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13:785\u201396.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"1979_CR4","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1128\/AAC.02166-13","volume":"58","author":"GL Daikos","year":"2014","unstructured":"Daikos GL, Tsaousi S, Tzouvelekis S, et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother. 2014;58(4):2322\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"1979_CR5","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1128\/AAC.01420-10","volume":"55","author":"CC Bulik","year":"2011","unstructured":"Bulik CC, Nicolau DP. Double-carbapenem therapy for carbapenemase- producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2011;55(6):3002\u20134.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"1979_CR6","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1086\/661597","volume":"32","author":"D Marchaim","year":"2011","unstructured":"Marchaim D, Chopra T, Perez F, et al. Outcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit Medical Center. Infect Control Hosp Epidemiol. 2011;32(9):861\u201371.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"9","key":"1979_CR7","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1111\/j.1469-0691.2011.03572.x","volume":"17","author":"ML Mezzatesta","year":"2011","unstructured":"Mezzatesta ML, Gona F, Caio C, et al. Outbreak of KPC-3-producing and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian Hospitals. Clin Microbiol Infect. 2011;17(9):1444\u20137.","journal-title":"Clin Microbiol Infect"},{"key":"1979_CR8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1471-2334-13-80","volume":"13","author":"L Correa","year":"2013","unstructured":"Correa L, Martino MDV, Siqueira I, et al. A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection. BMC Infect Dis. 2013;13:80.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"1979_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/1469-0691.12341","volume":"20","author":"F Kontopidou","year":"2014","unstructured":"Kontopidou F, Giamarellou H, Katerelos P, et al. Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care in Greece: a multi-centre study on clinical outcome and therapeutic options. Clin Microbiol Infect. 2014;20(2):117\u201323.","journal-title":"Clin Microbiol Infect"},{"key":"1979_CR10","doi-asserted-by":"crossref","unstructured":"Grundmann H, Livermore DM, Giske CK, et al. Carbapenem non- susceptible Enterobacteriaceae in Europe: conclusions from a meeting of a national experts. Euro Surveill. 2010;15(46):1-13.","DOI":"10.2807\/ese.15.46.19711-en"},{"issue":"2","key":"1979_CR11","doi-asserted-by":"publisher","first-page":"179.e1","DOI":"10.1016\/j.cmi.2014.07.010","volume":"21","author":"MS Oliveira de","year":"2015","unstructured":"de Oliveira MS, de Assis DB, Freire MP, et al. Treatment of KPC-producing Enterobacteriacea: suboptimal efficacy of polymyxins. Clin Microbiol Infect. 2015;21(2):179.e1\u20137.","journal-title":"Clin Microbiol Infect"},{"key":"1979_CR12","doi-asserted-by":"publisher","first-page":"E23","DOI":"10.1111\/1469-0691.12070","volume":"19","author":"A Capone","year":"2013","unstructured":"Capone A, Giannella M, Fortini D, et al. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin Microbiol Infect. 2013;19:E23\u201330.","journal-title":"Clin Microbiol Infect"},{"key":"1979_CR13","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1099\/jmm.0.023010-0","volume":"59","author":"RM Humphries","year":"2010","unstructured":"Humphries RM, Keledesis T, Bard JD, et al. Successful treatment of pan-resistant Klebsiella pneumoniae pneumonia and bacteraemia with a combination of high dose tigecycline and colistin. J Med Microbiol. 2010;59:1383\u20136.","journal-title":"J Med Microbiol"},{"issue":"2","key":"1979_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.diagmicrobio.2012.11.009","volume":"75","author":"D Duin van","year":"2013","unstructured":"van Duin D, Kaye KS, Neuner EA, Bonomo RA. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. Diagn Microbiol Infect Dis. 2013;75(2):115\u201320.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1979_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1476-0711-11-32","volume":"11","author":"GC Lee","year":"2012","unstructured":"Lee GC, Burgess DS. Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports. Ann Clin Microbiol Antimicrob. 2012;11:32\u201340.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"1979_CR16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","volume":"36","author":"T Horan","year":"2008","unstructured":"Horan T, Andrus M, Dudeck MA. CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309\u201332.","journal-title":"Am J Infect Control"},{"issue":"4","key":"1979_CR17","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","volume":"31","author":"MM Levy","year":"2003","unstructured":"Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31(4):1250\u20136.","journal-title":"Crit Care Med"},{"key":"1979_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"1979_CR19","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement, M100-S20","author":"CLS Institute","year":"2012","unstructured":"Institute CLS. Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement, M100-S20. CLSI: Wayne (PA); 2012."},{"key":"1979_CR20","unstructured":"European Committee on Antimicrobial Susceptibility Testing (Eucast). 2012."},{"key":"1979_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1086\/421495","volume":"39","author":"PA Bradford","year":"2004","unstructured":"Bradford PA, Bratu C, Urban M, et al. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactases in New York City. Clin Infect Dis. 2004;39:55\u201360.","journal-title":"Clin Infect Dis"},{"key":"1979_CR22","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/jac\/dkr082","volume":"66","author":"Y Chen","year":"2011","unstructured":"Chen Y, Zhou Z, Jiang Y, Yu Y. Emergence of NDM-1-producing Acinetobacter baumannii in China. J Antimicrob Chemother. 2011;66:1255\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"1979_CR23","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/jac\/dkr563","volume":"67","author":"J Monteiro","year":"2012","unstructured":"Monteiro J, Widen RH, Pignatari ACC. Rapid detection of carbapenemase genes by multiplex real time PCR. J Antimicrob Chemother. 2012;67:907\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"1979_CR24","volume-title":"Clinical microbiology procedures handbook","author":"MA Pfaller","year":"1993","unstructured":"Pfaller MA. Chromosomal restriction fragment analysis by pulsed-field gel electrophoresis. In: Isemberg HD, editor. Clinical microbiology procedures handbook. Washington: American Society for Microbiology; 1993."},{"issue":"4","key":"1979_CR25","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1128\/AAC.06268-11","volume":"56","author":"ZA Qureshi","year":"2012","unstructured":"Qureshi ZA, Paterson DL, Potoski BA, et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother. 2012;56(4):2108\u201313.","journal-title":"Antimicrob Agents Chemother"},{"key":"1979_CR26","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1086\/649865","volume":"50","author":"M Souli","year":"2010","unstructured":"Souli M, Galani I, Antoniadou A, et al. An outbreak of infection due to \u03b2-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek university hospital. Clin Infect Dis. 2010;50:364\u201373.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1979_CR27","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1093\/jac\/dkv086","volume":"70","author":"M Tumbarello","year":"2015","unstructured":"Tumbarello M, Trecarichi EM, De Rosa FG, et al. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicenter study. J Antimicrob Chemother. 2015;70(7):2133\u201343.","journal-title":"J Antimicrob Chemother"},{"key":"1979_CR28","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1111\/j.1469-0691.2011.03514.x","volume":"17","author":"O Zarkotou","year":"2011","unstructured":"Zarkotou O, Pournaras S, Tselioti P, et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect. 2011;17:1798\u2013803.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"1979_CR29","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1128\/AAC.00188-13","volume":"57","author":"G Ceccarelli","year":"2013","unstructured":"Ceccarelli G, Falconi M, Giordano A. Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin resistant KPC-producing K. pneumoniae. Antimicrob Agents Chemother. 2013;57(6):2900\u20131.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"1979_CR30","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1016\/j.transproceed.2013.07.064","volume":"45","author":"F Cicora","year":"2013","unstructured":"Cicora F, Mos F, Paz M, Allende NG, Roberti J. Infections with blaKPC-2-producing Klebsiella pneumoniae in renal transplant patients: a retrospective study. Transplant Proc. 2013;45(9):3389\u201393.","journal-title":"Transplant Proc"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1979-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-016-1979-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1979-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T03:46:29Z","timestamp":1568519189000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1979-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,3]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1979"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1979-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,3]]},"article-number":"629"}}